The Best Marijuana Stocks To Buy Right Now? 4 US stocks to watch before 2022
Invest in the best cannabis stocks before 2022
Like the best marijuana stocks to buy continue to show significant volatility in December, cannabis investors are gearing up for 2022. Although 2021 has started well for major cannabis stocks, congressional delays with federal cannabis reform have resulted in substantial declines in the cannabis industry. In December, most pot stocks hit their lowest trading levels this year. But these lower prices could be an opportunity for investors for 2022. As the cannabis sector begins to show some rise in trading from last week, next year could provide an upward momentum for stocks. of cannabis.
Invest in the American cannabis industry could be an important growth factor for the next five years. In the United States, more and more states continue to establish medical and recreational markets by expanding the industry. In 2021, many large cannabis companies saw strong growth in profits and revenues. While this did not translate into market gains, it does show a rapidly growing market where the major cannabis companies are making headway.
As the cannabis market continues to grow at the state level, these companies are growing rapidly by establishing their market share and presence in the industry. Currently, many analysts are forecasting a significant rise for some of the best marijuana stocks to buy. As the cannabis industry has experienced intense volatility this year due to federal legalization, there is currently potential for cannabis investors in American jar stocks.
Finding the best pot stocks for 2022
Before investing in best stocks of cannabis, it is important to do your research on a business. Examining a company’s financial data and studying the performance of a stock in the market can help you achieve the best returns. As the market continues its year-end rally, let’s look at 4 best marijuana stocks for your 2022 watchlist right now.
[Read More] 3 best marijuana stocks for your 2022 watchlist
Best US Marijuana Stocks to Watch Before 2022
- Ayr Well-being Inc. (OTC: AYRWF)
- Verano Holdings Corp. (OTC: VRNOF)
- Curaleaf Holdings, Inc. (OTC: CURLF)
- Columbia Care Inc. (OTC: CCHWF)
Ayr Well-being Inc.
First on the list is Ayr Wellness Inc. which has built a strong presence in the Florida cannabis market. Currently, the company operates 42 dispensaries in Florida and a total of 59 stores nationwide. In addition, the company entered the Illinois market with the acquisition of Herbal Remedies Dispensaries, LLC. Ayr was given a provisional license to sell cannabis for adult use at dispensaries in Greater Boston, Massachusetts. In October, the company launched the premium Kynd flower in Arizona. In addition, the company opened its seventh affiliated operating dispensary in Pennsylvania. In December, Ayr received approval to start operations at its 86,000 square foot cultivation and production facility in Arizona.
Ayr released its third quarter 2021 results with revenue of $ 96.2 million, up 111% year-over-year. Overall, the company had adjusted EBITDA of $ 26 million, up 40% year over year. Ayr incurred a US GAAP operating loss of $ 8.9 million, which includes a one-time expense and non-operating adjustments of $ 34.9 million. In addition, the company provided a forecast for Q4 2021 for sequential growth of over 10% and stable Adjusted EBITDA from Q3 to Q4. For 2022, Ayr revised its adjusted EBITDA target to $ 250-300 million and maintained a 2022 revenue target of $ 800 million.
AYRWF share performance
Closing of AYRWF title on December 10e to $ 14.50, down 32.27% over the past month. Currently, the stock has a 52-week price range of $ 14.00 to $ 37.50 and is down 39.02% year-to-date. According to analysts at Tip Ranks, AYRWF stock has a 12-month average price target of $ 42.03 per share. Essentially, that would be an 189.86% rise from its last stock price of $ 14.50.
Verano Holdings Corp.
Next up is Verano Holdings, one of the largest multi-state operators providing regulated cannabis products to U.S. cannabis consumers. In general, the company manufactures premium cannabis products sold under its portfolio of consumer brands. To highlight, Verano has active operations in 11 states with 90 nationwide operational dispensaries and 12 cultivation and processing facilities. Specifically, in Florida, the company has 40 dispensaries, which represents a significant presence in this market. Verano expects to exceed 92 dispensaries in 2021. Specifically, the company operates dispensaries under the Zen Leaf retail brands. and MUV addressing both medical and adult markets. In October, the company opened a drive-thru dispensary on Flamingo Road in Las Vegas. December 9e the company announced the opening of its 11e CUV dispensary in 2021 in Orange Park, Florida.
Verano recently completed the acquisition of TerraVida and The Healing Center. Ultimately, this acquisition gives Verano six dispensaries in Pennsylvania and a license to build three more in the state. Earlier this year, the company opened a flagship Pittsburgh dispensary with a four-lane drive-thru. In November, the company announced its third quarter 2021 results with revenue of $ 207 million, up 106% year on year. Additionally, gross margin increased 33% sequentially on an unadjusted basis to $ 133 million or 64% of sales. In the third quarter, Verano expanded its presence with seven new dispensaries in its main markets.
VRNOF share performance
VRNOF title closes on December 10e at $ 11.81, up 5.73% over the past five trading days. Currently, the stock has a 52-week price range of $ 9.86 to $ 28.00 and has fallen 37.35% in the past six months. According to Market Beat analysts, VRNOF stock has a consensus price target of $ 33.25 per share. In this case, that would represent an increase of 181.5% from its last stock price.
Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. is a US multi-state operator that supplies packaged cannabis products and operates 113 retail outlets nationwide. Additionally, the company has also started to expand with Curaleaf International advancing the accessibility of medical cannabis products in Germany through its wholly owned subsidiary Adven GmbH. Curaleaf has the popular Select brand, one of its main brands in the United States. In November, Curaleaf expanded its presence in three states with the acquisition of Tryke Companies. This acquisition adds assets in Arizona, Nevada and Utah. In addition, the important Curaleaf has advanced its B Noble partnership in ten states, including the New York medical market.
In November, Curaleaf released its third quarter 2021 results with revenue of $ 317 million, up 74% year-over-year. In detail, the company had adjusted EBITDA of $ 71 million, a 69% year-over-year increase. Curaleaf had cash flow from operations in the third quarter of 2021 of $ 52 million or 16% of revenue. As a result, gross profit in the third quarter of 2021 on cannabis sales was $ 144 million, up 61% year on year. The company also completed the acquisition of Los Suenos Farms, bringing its current cultivation capacity to 4.4 million square miles. Last month, the company opened its 38e Florida Dispensary in Spring Hill.
Return on CURLF shares
CURLF stock closes at $ 9.50 on December 10e down 35.33% in the last six months. Right now, the stock has a 52-week price range of $ 8.21 to $ 18.38 and is down 22.90% year-to-date. According to analysts at Tip Ranks, CURLF stock has a 12-month average price target of $ 18.70 per share. This forecast represents an increase of 96.84% from its last stock price of $ 9.50.
Columbia Care Inc.
Columbia Care Inc. is positioned for significant growth in New York State. Recently, the company acquired a 34-acre grow site on Long Island, which has given the company one of the largest cannabis footprints to serve the East Coast market. Currently, Columbia Care operates in 18 US markets and operates 130 facilities, including 99 dispensaries and 31 growing and manufacturing facilities. In October, the company opened a cannabis dispensary in Missouri, its first location in the state. This month, the company announced the opening of its third dispensary in Virginia under the gLeaf brand. Additionally, in November, Columbia Care announced that it was bringing the highly anticipated Tyson 2.0 Cannabis brand from heavyweight champion Mike Tyson to Colorado. December 8e the company announced a rebranding in the Florida market and its outlets. The company will be launching its new Cannabist retail design and experience soon.
Columbia Care released its third quarter 2021 results with record quarterly revenue of $ 132 million, up 144% year-over-year. Overall, the company posted a record quarterly adjusted gross profit of $ 64.5 million, a 205% year-over-year increase. In addition, the company had an adjusted gross margin of 49% and a record Adjusted EBITDA of $ 31 million, up 634% year over year. The company revised its guidance for 2021 to $ 470-485 million and its adjusted EBITDA from $ 85 million to $ 95 million. In September, the company received state approval to rename its business footprint across all of its 14 locations in Florida.
CCHWF Share Return
Closing of the CCHWF title on December 10e at $ 3.12, up 5.41% over the past five trading days. Currently, the stock has a 52-week price range of $ 2.79 to $ 7.89 and is down 48.43% year-to-date. According to CNN Business analysts, CCHWF stock has a 12-month median price target of $ 10.00 per share. In this case, that would represent a rise of 220.51% from its last price of $ 3.12.
COMTEX_398777821 / 2683 / 2021-12-12T11: 03: 13
Is there a problem with this press release? Contact the source supplier Comtex at [email protected]